| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 88.28B | 75.22B | 72.05B | 66.60B | 119.65B |
| Gross Profit | 88.28B | 78.67B | 63.42B | 70.31B | 119.65B |
| EBITDA | 7.97B | 11.06B | 8.59B | 7.47B | 8.81B |
| Net Income | 6.14B | 5.45B | 3.74B | 4.49B | 5.88B |
Balance Sheet | |||||
| Total Assets | 673.63B | 581.79B | 513.69B | 453.57B | 412.48B |
| Cash, Cash Equivalents and Short-Term Investments | 21.77B | 6.71B | 306.00B | 186.94B | 166.19B |
| Total Debt | 47.76B | 20.10B | 20.06B | 12.91B | 13.85B |
| Total Liabilities | 608.86B | 518.38B | 451.90B | 394.22B | 360.72B |
| Stockholders Equity | 58.23B | 62.08B | 60.45B | 58.08B | 50.55B |
Cash Flow | |||||
| Free Cash Flow | 80.62B | 32.00B | 18.28B | 24.48B | 42.88B |
| Operating Cash Flow | 81.24B | 32.60B | 20.33B | 25.92B | 44.57B |
| Investing Cash Flow | -79.58B | -37.62B | -36.41B | -28.41B | -4.69B |
| Financing Cash Flow | 7.15B | -9.68B | 18.13B | 1.88B | -26.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$75.91B | 2.48 | 29.19% | 1.81% | 23.64% | 36.32% | |
68 Neutral | HK$51.17B | 6.52 | 10.97% | 5.22% | 8.20% | 42.29% | |
68 Neutral | HK$62.02B | 1.89 | 10.53% | 3.22% | 2.54% | 17.80% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | HK$55.72B | 13.34 | 3.90% | 1.18% | 365.12% | 170.00% | |
55 Neutral | HK$21.52B | 14.26 | 5.72% | ― | -2.69% | -68.97% |